A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases
Plummer, Ruth, Greystoke, Alastair, Naylor, Gregory, Sarker, Debashis, Anam, A N M Kaiser, Prenen, Hans, Teuwen, Laure-Anne, Van Cutsem, Eric, Dekervel, Jeroen, Haugk, Beate, Ness, Thomas, Bhoi, Sujata, Jensen, Malene, Morris, Tom, Baumann, Pia, Sjögren, Niclas, Tunblad, Karin, Wallberg, Hans, Öberg, Fredrik, Evans, Thomas R Jeffry
Published in Journal of hepatocellular carcinoma (01.01.2024)
Published in Journal of hepatocellular carcinoma (01.01.2024)
Get full text
Journal Article
75 Real world toxicity data for the use of ipilimumab plus nivolumab in malignant mesothelioma
Harriet, McGrath, Anam, Kaiser, Morton, Cienne, Gennatas, Spyridon, Ghosh, Sharmistha, Karapanagiotou, Eleni, Georgiou, Alexandras, Spicer, James
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2024)
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2024)
Get full text
Journal Article
Abstract P036: Trial in progress: Combination of the dual RAF/MEK inhibitor VS-6766 with the mTOR inhibitor everolimus with expansion in patients with KRAS mutant NSCLC
Manickavasagar, Thubeena, Stavraka, Chara, Anam, Kaiser, Coma, Silvia, Chowdhury, Sanjib, Pachter, Jonathan A., Parker, Tom, Parmar, Mona, Finneran, Laura, Hall, Emma, Spicer, James, Minchom, Anna, Banerji, Udai
Published in Molecular cancer therapeutics (01.12.2021)
Published in Molecular cancer therapeutics (01.12.2021)
Get full text
Journal Article
Evaluation of an automated artificial intelligence (AI)/ natural language processing (NLP) engine to match patients (pts) with advanced solid cancers to biomarker-driven early phase (EP) clinical trials
Morton, Cienne, Ruta, Daniel, Stavraka, Chara, Anam, Kaiser, Spicer, James F., Regan, Aoife, Sengul, Siru, Cernile, George, Borecki, Yulia, Schwering, Taralyn, Rai, Harpreet, Brierley, Phil, Duroe, Oenone, Quarterman, Alan, Sarker, Debashis
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Abstract CT101: Final results of the first-in-human study of the porcupine (PORCN) inhibitor zamaporvint (RXC004) in patients with advanced solid tumors
Cook, Natalie, Blagden, Sarah, Lopez, Juanita, Sarker, Debashis, Greystoke, Alastair, Haris, Noor MD, Kazmi, Farasat, Anam, Kaiser, Franco, Ana Ortego, Pihlak, Rille, Goodwin, Louise, Wilson, David, Phillips, Caroline, Robertson, Jane, Timmis, Helen, Tilston, Craig, Woodcock, Simon A., Plummer, Ruth
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Get full text
Journal Article